- Report
- January 2023
- 174 Pages
North America
From €3280EUR$3,450USD£2,755GBP
- Report
- October 2022
- 191 Pages
Asia Pacific
From €3280EUR$3,450USD£2,755GBP
- Report
- July 2022
- 150 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- October 2023
- 145 Pages
Global
From €2995EUR$3,150USD£2,516GBP
- Report
- August 2022
- 120 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- December 2023
- 170 Pages
Global
From €3421EUR$3,599USD£2,874GBP
- Report
- July 2023
- 140 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- December 2023
- 246 Pages
Global
€4749EUR$4,995USD£3,989GBP
- Report
- October 2023
Middle East, Africa
From €1426EUR$1,500USD£1,198GBP
- Report
- February 2024
- 109 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- February 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Book
- November 2019
- 440 Pages

Glycomics is a branch of biotechnology that focuses on the study of carbohydrates, or glycans, and their roles in biological processes. Glycans are complex molecules that are found in all living organisms and are involved in a variety of biological functions, including cell-cell recognition, cell adhesion, and immune system regulation. Glycomics research has been used to develop new treatments for diseases such as cancer, diabetes, and Alzheimer's.
The glycomics market is driven by the increasing demand for new treatments for various diseases, as well as the growing need for personalized medicine. The market is expected to grow at a steady rate due to the increasing number of research and development activities in the field.
Some of the major companies in the glycomics market include GlycoMimetics, Inc., GlycoBioTech, Inc., GlycoVaxyn AG, GlycoMark, Inc., and GlycoThera, Inc. Show Less Read more